
Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2024-2030
Description
Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2024-2030
The Malaria Vaccine Market size was estimated at USD 64.34 million in 2023 and expected to reach USD 80.88 million in 2024, at a CAGR 25.78% to reach USD 320.66 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Malaria Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Malaria Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Malaria Vaccine Market, highlighting leading vendors and their innovative profiles. These include Amyris, Inc., Bharat Biotech International Limited, Cadila Healthcare Ltd., CellFree Sciences Co.,Ltd., GenVec, Inc., GlaxoSmithKline PLC, Ipca Laboratories Limited, Merck & Co., Inc, Mymetics Corporation, Novartis AG, Novavax, Inc., Precigen, Inc., Sanaria Inc., Sumaya Biotech, and Sun Pharmaceutical Industries Limited.
Market Segmentation & Coverage
This research report categorizes the Malaria Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Erythrocytic Vaccine
Multi-Antigen Vaccine
Pre-Erythrocytic Vaccine
Agent
Anopheles Species
Plasmodium Falciparum
Plasmodium Vivax
End-User
Clinics
Community Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Malaria Vaccine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Malaria Vaccine Market?
3. What are the technology trends and regulatory frameworks in the Malaria Vaccine Market?
4. What is the market share of the leading vendors in the Malaria Vaccine Market?
5. Which modes and strategic moves are suitable for entering the Malaria Vaccine Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Malaria Vaccine Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Proliferation in the number of routine immunizations programs
- 5.1.1.2. Rising availability, accessibility and favorable government support for malaria vaccine
- 5.1.1.3. Growing patient awareness and incidence of malaria
- 5.1.2. Restraints
- 5.1.2.1. High cost of the vaccines
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
- 5.1.3.2. Rising advancements in pharmaceutical industry for vaccines
- 5.1.4. Challenges
- 5.1.4.1. Rigid regulative scenarios
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Malaria Vaccine Market, by Type
- 6.1. Introduction
- 6.2. Erythrocytic Vaccine
- 6.3. Multi-Antigen Vaccine
- 6.4. Pre-Erythrocytic Vaccine
- 7. Malaria Vaccine Market, by Agent
- 7.1. Introduction
- 7.2. Anopheles Species
- 7.3. Plasmodium Falciparum
- 7.4. Plasmodium Vivax
- 8. Malaria Vaccine Market, by End-User
- 8.1. Introduction
- 8.2. Clinics
- 8.3. Community Centers
- 8.4. Hospitals
- 9. Americas Malaria Vaccine Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Malaria Vaccine Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Malaria Vaccine Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Amyris, Inc.
- 13.1.2. Bharat Biotech International Limited
- 13.1.3. Cadila Healthcare Ltd.
- 13.1.4. CellFree Sciences Co.,Ltd.
- 13.1.5. GenVec, Inc.
- 13.1.6. GlaxoSmithKline PLC
- 13.1.7. Ipca Laboratories Limited
- 13.1.8. Merck & Co., Inc
- 13.1.9. Mymetics Corporation
- 13.1.10. Novartis AG
- 13.1.11. Novavax, Inc.
- 13.1.12. Precigen, Inc.
- 13.1.13. Sanaria Inc.
- 13.1.14. Sumaya Biotech
- 13.1.15. Sun Pharmaceutical Industries Limited
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. MALARIA VACCINE MARKET RESEARCH PROCESS
- FIGURE 2. MALARIA VACCINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. MALARIA VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. MALARIA VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. MALARIA VACCINE MARKET DYNAMICS
- FIGURE 7. MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. MALARIA VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2030 (%)
- FIGURE 10. MALARIA VACCINE MARKET SIZE, BY AGENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. MALARIA VACCINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.